Sodium Salicylate

HCID 16760658CAS 54-21-7

Teilstruktursuche Ähnliche Strukturen suchen

Grundinformationen

Standard-SMILES: O=C([O-])c1ccccc1O.[Na+]
InChIKey: ABBQHOQBGMUPJH-UHFFFAOYSA-M
Summenformel: C7H5NaO3
Durchschnittliche Molmasse: 160,1 g/mol
Monoisotopische Masse: 160,0136383

Überblick

Sodium salicylate is an organic molecular entity.

Namen und Bezeichner

Bevorzugter Name: Sodium Salicylate
IUPAC: sodium 2-hydroxybenzoate
Englischer Name: Benzoic acid, 2-hydroxy-, monosodium salt, coupled with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 2-(4-aminophenyl)-1H-benzimidazol-5-amine and diazotized 4-nitrobenzenamine, sodium salt
Summenformel: C7H5NaO3
Molmasse: 160.10257

Namen und Synonyme

Sodium salicylate54-21-7EnterosalicylKerasalicylAlysineBenzoic acid, 2-hydroxy-, monosodium saltNatrum salicylicumSalicylic acid sodium saltsalicylate sodiumDTXSID5021708Monosodium 2-hydroxybenzoateNatrii salicylas

Weitere Namen anzeigen

Benzoic acid, 2-hydroxy-, monosodium salt, coupled with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 2-(4-aminophenyl)-1H-benzimidazol-5-amine and diazotized 4-nitrobenzenamine, sodium salt

WIQ1H85SYPSalicylate, sodiumNSC-202167DTXCID701708Benzoic acid, 2-hydroxy-, sodium salt (1:1)NSC202167Sod salPro-Prin

Datenbank-Bezeichner

CAS: 54-21-7、90218-94-3
PubChem CID: 16760658
DTXSID: DTXSID5021708
ChEMBL: CHEMBL447868
ChEBI: CHEBI:9180
UNII: WIQ1H85SYP
EC Number: 200-198-0、290-774-8

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA): 60,4 Å²
H-Brücken-Donoren: 1
H-Brücken-Akzeptoren: 3
Frei drehbare Bindungen: 1
Schwere Atome: 11
Formalladung: 0
Komplexität: 138

Experimentelle und physikochemische Eigenschaften

Cosmetics · 2 Einträge

Cosmetic ingredients (Sodium Salicylate) -> CIR (Cosmetic Ingredient Review)

Preservative

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List

Food Contact Substances · 4 Einträge

FCS -> FDA Cumulative Estimated Daily Intake (CEDI)

FCS -> FDA Inventory of Food Contact Substances Listed in 21 CFR

FCS -> FDA Inventory of Effective Food Contact Substance (FCS) Notifications

Physical DescriptionDry Powder

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 0.7% (3 of 441) of reports.

Warning

H302 (96.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 441 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

Gefahrenhinweise

Regulatory Information · 4 Einträge

Chemical: Benzoic acid, 2-hydroxy-, sodium salt (1:1)

Benzoic acid, 2-hydroxy-, sodium salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Benzoic acid, 2-hydroxy-, sodium salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 17-06-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/13593

Sodium salicylate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Salicylic acid and its salts: Human health tier II assessment

Hazard Classes and Categories · 2 Einträge

Acute Tox. 4 (96.4%)

Acute toxicity - category 4

Toxikologische Informationen

Toxicity Summary · 2 Einträge

The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Sodium Salicylate...

Safe for use in cosmetics, with qualifications

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 2 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.